Tectonic Therapeutic (TECX) Capital Expenditures (2017 - 2026)
Tectonic Therapeutic (TECX) has 10 years of Capital Expenditures data on record, last reported at $19000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 29.63% to $19000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $200000.0, a 11.73% increase, with the full-year FY2025 number at $208000.0, up 33.33% from a year prior.
- Capital Expenditures reached $19000.0 in Q1 2026 per TECX's latest filing, down from $181000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for TECX hit a ceiling of $267000.0 in Q4 2022 and a floor of -$181000.0 in Q3 2022.
- A 5-year average of $61933.3 and a median of $27000.0 in 2025 define the central range for Capital Expenditures.
- Peak YoY movement for Capital Expenditures: crashed 167.79% in 2022, then soared 2085.71% in 2024.
- Tracing TECX's Capital Expenditures over 5 years: stood at $267000.0 in 2022, then tumbled by 81.27% to $50000.0 in 2023, then crashed by 94.0% to $3000.0 in 2024, then surged by 5933.33% to $181000.0 in 2025, then plummeted by 89.5% to $19000.0 in 2026.
- Business Quant data shows Capital Expenditures for TECX at $19000.0 in Q1 2026, $181000.0 in Q3 2025, and $27000.0 in Q1 2025.